Evidence map›Paper›PMID 22219582›Full record

ArticleJournal of pharmacy & bioallied sciences2011

Bacterial vaginosis: Etiology and modalities of treatment-A brief note.

Nikhil Kumar, Beauty Behera, Sai S Sagiri, Kunal Pal, Sirsendu S Ray, Saroj Roy

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. IL-33 Participates inJournal of inflammation research · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Astodrimer sodium and bacterial vaginosis: a mini review.Archives of gynecology and obstetrics · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Bacterial Vaginosis: What Do We Currently Know?Frontiers in cellular and infection microbiology · 2021
    Review
  14. Review
  15. Diagnostic performance of two molecular assays for the detection of vaginitis in symptomatic women.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  16. Article
  17. Article
  18. New microbes and new infections · 2019
    Article
  19. Article
  20. New microbes and new infections · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nikhil KumarDepartments of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, India.
Beauty Behera
Sai S Sagiri
Kunal Pal
Sirsendu S Ray
Saroj Roy
National Institute of Technology Rourkela · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large women population of the world is suffering from a vaginal infection commonly known as bacterial vaginosis. The disease is associated with the decrease in the lactobacilli count in the vagina. Till date, there is a lack of full proof treatment modalities for the cure of the disease. The treatment includes the use of antimicrobials and/or acidifying agents and probiotics, either separately or in combination. This note discusses about the etiology and the various present-day modalities of treatment of bacterial vaginosis.

Indexed as

Antimicrobialsbacterial vaginosislactobacilliprobioticssexual intercoursevagina

Identifiers

PMID22219582
PMCPMC3249696
OpenAlexW1968676797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.